Psychiatric Medications Flashcards
(40 cards)
Anti-depressants
- Common mechanism of action
- Common time needed
Anti-depressants
- Common mechanism of action
- Common time needed
- Serotonin activity
- increase activity at post-synaptic receptor - 2-4 weeks
SSRIs
- Mechanism
SSRIs
- Mechanism
- Reduce pre-synaptic uptake
- Increased junction serotonin
- Down-regulation of post-synaptic receptors
SSRIs
- ADRs
- Short term
- Uncommon
- Personal sx
- Important
SSRIs
- ADRs
- Short term
- restlessness/agitation
- GI/Nausea
- Headache - Weight change
- personal
Sexual dysfunction
- low libido
- failure to orgasm - important
- Bleeding risk esp when with NSAID (eg. PPI with aspirin)
- Suicidal ideation
(Young men, first few weeks)
SSRIs
- 4 commonest (dose)
- Choosing
SSRIs
- Commonest & Use
- Sertraline (50-200)
- Safe in heart disease - Citalopram (20-40)
- QTc prolongation
- Escitalopram (10-20) - Fluoxetine (20-60) (prozac)
- Serotonin syndrome when switching - Paroxetine (20-60)
- Discontinuation syndrome
SNRIs
- Mechanism
- Uses
SNRIs
- Mechanism
1. Reduce pre-synaptic uptake
2. Increased junction serotonin (and NA)
3. Down-regulation of post-synaptic receptors - Uses
1. Evidence for neuropathic pain
2. Similar to SSRIs
SSRIs vs SNRIs
- Effects
SSRIs vs SNRIs
- Effects
SNRI
1. Greater sedation
2. Greater Nausea
3. Greater Sexual dysfunction
SNRIs
- 2 examples (doses)
SNRIs
- 2 examples (doses)
- Duloxetine (60-120mg)
- Venlafaxine (75-375mg)
- More efficacious
- Higher dose tolerated
- Caution in heart disease (BP)
Mirtazepine
- Mechanism
- Activity and ADRs
Mirtazepine
- Mechanism:
1. A2-Adrenoreceptor antagonist
Increases noradrenaline and serotonin - Activity and ADRs
1. Strong H1 activity (sedation)
2. Weight gain
Tricyclic Antidepressants
- ADRs
Tricyclic Antidepressants
- ADRs
- Muscarinic (dry mouth, constipation, blurred vision, and urinary retention)
- Histaminic (sedation)
- Overdose
- QTc prolongation
- Arrythmias
MAOIs
- Types
- Examples (reversible/irreversible)
- ADRs
Monoamine oxidase inhibitors
- Types
1. MAOi - A
More serotonin
2. MAOi - B
More on dopamine - Examples
1. Reversible
Moclobamide
Tranylcypromine
2. Irreversible
Phenelzine
Isocarboxazid - ADRs
1. Serious interactions
2. Tyramine reaction
HTN crisis
Avoid tyramine foods (cheese, pickled meats, wine)
3. 6 week washout period before new AD
ADs
- Dose changing
ADs
- Dose changing
- Depression
- If no effect, switch, don’t increase - Anxiety
- If no effect, consider increasing - ADRs
- May improve in 2 weeks
- Consider switching if problem
Discontinuation syndrome of AD
- Character
- Causes
- how to avoid
Discontinuation syndrome
- Character
1. Shakes,
2. Agitation, insomnia
3. Headaches, N&V
4. Paresthesia, clonus - Causes
1. Short half lives
2. Paroxetine & Venlafaxine - how to avoid
1. Slow taper
2. Consider Fluoxetine cover
Serotonin syndrome
- Cognitive
- Autonomic
- Somatic
- Treatment
Serotonin syndrome
- Cognitive
1. Headaches, agitation
2. Hypomania, confusion
3. Coma - Autonomic
1. Shivering, sweating
2. Hyperthermia, tachycardia
3. N&D - Somatic
1. Myoclonus, hyper-reflexia
2. Tremor - Treatment
0. Stop treatment
1. Fluids
2. Monitoring
3. Seizure Meds
Antipsychotics
- receptor
- Pathways
- Unwanted pathways
Antipsychotics
- receptors
1. D2 receptors (typical)
2. D2, D3, D4, 5-HT (atypical) - Pathways
1. Mesocortical
2. Mesolimbic - Unwanted pathways
1. Nigrostriatal
2. Tuberoinfundibular (HPA)
Antipsychotics
ADRs
- EPSE (ADAPT)
- elderly
- other
- serious
Extrapyramidal side-effects (EPSEs)
ADAPT:
- Acute Dystonia
- Akathisia
- Parkinsonism
- Tardive dyskinesia
elderly patients:
- increased risk of stroke
- increased risk of VTE
other:
- antimuscarinic
- sedation, weight gain
- raised prolactin
- impaired glucose tolerance
serious:
- neuroleptic malignant syndrome
- reduced seizure threshold
- prolonged QT interval
Antipsychotics
- Typical vs Atypical
- ADRs
Antipsychotics
- Typical
1. Extrapyramidal - Atypical
1. weight gain
3. metabolic e.g lipid, glucose,
Antipsychotics
- 3 Typicals
- 5 Atypicals
Antipsychotics
- 3 Typicals
1. Haloperidol
2. Chlorpromazine
3. Flupenthixol - 5 Atypicals
1. Clozapine
2. Olanzapine
3. Risperidone
4. Quetiapine
5. Aripiprazole
D2 partial agonist
No QTC
Tardive dyskinesia
- Signs
Tardive dyskinesia
- Signs
- Involuntary mouth movements
- Chewing
- Tongue movements - Sometimes throat
Akathisia
Akathisia - inability to remain still
- Signs
- Involuntary movements
- Especially leg movements
acute dystonia
- 2 examples
- Mx
torticollis:
- involuntary muscle contractions in the neck, leading to abnormal postures and movements
oculogyric crisis:
- involuntary upward eye movement
- often accompanied by other symptoms such as neck extension and facial grimacing
- procyclidine
Antipsychotic monitoring
- Baseline
- Weekly
- Three months
- 6m
- Yearly
Antipsychotic monitoring
- Baseline
- HR & BP
- Weight, ECG
- FBC, Lipids, LFT, HbA1C - Weekly
- Weight - Three months after starting
- As baseline - Six months after starting
- prolactin - Yearly
- As baseline
Clozapine
- Indication
- ADRs
- Monitoring
Clozapine
- Indication
1. Schizophrenia
2. After 2 others (3rd line) - ADRs
1. Agranulocytosis 1% (3% neutropenia)
2. Gastrointestinal hypomobility
3. Seizures - Baseline
0. BMI, ECG, HR, BP
1. FBCs
2. U&E, LFT, Trop, and Prolactin - FBC
1. Weekly to 18 weeks
2. Fortnightly from 18 weeks
3. Monthly from 1 year
Extra-pyramidal ADRs
- cause
- Mx
- Dx ADRs
Extra-pyramidal ADRs
- Mx
- Nigrostriatal pathway
- Dopamine: ACh - Anticholinergics
- Procyclidine - ADRs of Tx
- anticholinergic SEs
Anxiety
- Tx (Drugs)
Anxiety
- Tx (Drugs)
- Beta blockers for physical sx
- Benzos
- ADs
- Pregabalin